|
|
Volumn 30, Issue 6, 2009, Pages 199-206
|
|
Depression and suicide in children and adolescents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTIVIRUS AGENT;
BIOLOGICAL MARKER;
FLUOXETINE;
GLUCOCORTICOID;
IMMUNOSUPPRESSIVE AGENT;
ISOTRETINOIN;
PARACETAMOL;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
AGITATION;
ANXIETY DISORDER;
ATTENTION DEFICIT DISORDER;
AUTOMUTILATION;
BEHAVIOR THERAPY;
CHILD BEHAVIOR;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
COMORBIDITY;
CONDUCT DISORDER;
COUNSELING;
DAILY LIFE ACTIVITY;
DEPRESSION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
ENVIRONMENTAL STRESS;
GENETIC ASSOCIATION;
GENETIC LOAD;
GESTURE;
HUMAN;
MENTAL HEALTH;
MENTAL STRESS;
MOOD CHANGE;
MOOD DISORDER;
NAUSEA AND VOMITING;
NEUROIMAGING;
PSYCHOPHARMACOLOGY;
PSYCHOSIS;
PSYCHOTHERAPY;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
SLEEP DISORDER;
SOCIAL INTERACTION;
SOCIAL ISOLATION;
SUBSTANCE ABUSE;
SUICIDAL BEHAVIOR;
SUICIDAL IDEATION;
SUICIDE;
SUICIDE ATTEMPT;
TREATMENT RESPONSE;
VIVID DREAM;
ADOLESCENT;
CHILD;
EARLY DIAGNOSIS;
FEMALE;
HOSPITALIZATION;
INCIDENCE;
MALE;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
SELF HELP;
STATISTICS;
SURVIVAL;
UNITED STATES;
ADOLESCENT;
BEHAVIOR THERAPY;
CHILD;
COMBINED MODALITY THERAPY;
DEPRESSIVE DISORDER;
EARLY DIAGNOSIS;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
PROGNOSIS;
PSYCHOTHERAPY;
RISK ASSESSMENT;
SELF-HELP GROUPS;
SEROTONIN UPTAKE INHIBITORS;
SEVERITY OF ILLNESS INDEX;
SUICIDE;
SURVIVAL ANALYSIS;
UNITED STATES;
|
|
EID: 68849091291
PISSN: 01919601
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.30-6-199 Document Type: Review |
|
Times cited : (35)
|
|
References (13)
|
